ACTIVE

NADIMED

Financial year 2026 · closed on 31/03/2026
Net result
112,1 k €
-81.5% YoY
Revenue
13 M €
+7.0% YoY
Equity
822 k €
-32.9% YoY
Workforce
4,3 ETP
+38.7% YoY

What does NADIMED do?

NADIMED is a Private limited company incorporated in 2003. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Kontich. It employs on average 4,3 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0859.727.529
Incorporation
23/07/2003
Legal form
Private limited company
Registered office
Prins Boudewijnlaan 7b box 18
2550 Kontich · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/03/2026
Average workforce
4,3 ETP
Joint committees (1)
  • 200
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 8 financial years

20262025202420222021200820072006
Income statement
Revenue13 M €12,2 M €15,1 M €
EBITDA240,5 k €549,6 k €993,8 k €1,9 M €1,8 M €165,7 k €175,5 k €67,4 k €
Operating result148,7 k €503,5 k €926,6 k €1,8 M €1,7 M €153,1 k €158,3 k €57,9 k €
Net result112,1 k €607,6 k €808,3 k €1,4 M €1,3 M €102,3 k €104,2 k €43,1 k €
Balance sheet
Equity822 k €1,2 M €5,2 M €5,2 M €3,8 M €225,4 k €123,2 k €147,6 k €
Total assets2,3 M €3,1 M €6,9 M €6 M €5,1 M €299 k €321,7 k €160,9 k €
Cash815 k €1,7 M €1,5 M €3,6 M €3 M €195,6 k €125,4 k €75,7 k €
Debts1,4 M €1,9 M €1,8 M €794,3 k €1,3 M €73,5 k €198,5 k €13,3 k €
Other
Workforce4,3 ETP3,1 ETP2,7 ETP2,4 ETP2,6 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/03/2026 · 1 active · 6 ended

Active mandates

William Sanders

Director · since 09 janvier 2023

Active

Ended mandates

ELINOVA

Director · since 09 janvier 2024 · until 10 septembre 2025 · 0803.579.375

Represented by Elisabeth MATTHEUSSENS

Ended
ELINOVA

Director · since 09 janvier 2024 · 0803.579.375

Represented by Elisabeth MATTHEUSSENS

Ended
Nadine Maes

Bestuurder · since 10 juillet 2003

Ended
Nadine Maes

Director · since 10 juillet 2003

Ended
At this address

Other companies at this address

CompanyCBE no.
INDUCAMActive
0447.471.292
0795.892.621
Annual accounts

Full financial information

202620252024202220212020
Type of accountFull modelFull modelFull modelAbridged modelAbridged modelAbridged model
Start of the financial year01/04/202501/04/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/03/202631/03/202531/03/202431/12/202231/12/202131/12/2020
Length of the financial year12 months12 months15 months12 months12 months12 months
Filing date15/09/202608/10/202524/09/202403/07/202319/08/202224/06/2021
General meeting10/09/202611/09/202523/09/202429/06/202325/07/202225/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

20 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/03/202610/09/202615/09/2026DutchPDF
Full model31/03/202511/09/202508/10/2025DutchPDF
Full model31/03/202423/09/202424/09/2024DutchPDF
Abridged model31/12/202229/06/202303/07/2023DutchPDF
Abridged model31/12/202125/07/202219/08/2022DutchPDF
Abridged model31/12/202025/05/202124/06/2021DutchPDF
Abridged model31/12/201926/05/202025/06/2020DutchPDF
Abridged model31/12/201828/05/201927/06/2019DutchPDF
Abridged model31/12/201729/05/201812/06/2018DutchPDF
Abridged model31/12/201630/05/201706/06/2017DutchPDF
Abridged model31/12/201531/05/201616/06/2016DutchPDF
Abridged model31/12/201426/05/201501/06/2015DutchPDF
Abridged model31/12/201327/05/201428/05/2014DutchPDF
Abridged model31/12/201228/05/201314/06/2013DutchPDF
Abridged model31/12/201129/05/201212/06/2012DutchPDF
Abridged model31/12/201031/05/201101/06/2011DutchPDF
Abridged model31/12/200925/05/201002/06/2010DutchPDF
Abridged model31/12/200826/05/200927/05/2009DutchPDF
Abridged model31/12/200727/05/200806/06/2008DutchPDF
Abridged model31/12/200629/05/200730/05/2007DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2026 · 1 active · 6 ended

Active mandates

William Sanders

Director · since 09 janvier 2023

Active

Ended mandates

ELINOVA

Director · since 09 janvier 2024 · until 10 septembre 2025 · 0803.579.375

Represented by Elisabeth MATTHEUSSENS

Ended
ELINOVA

Director · since 09 janvier 2024 · 0803.579.375

Represented by Elisabeth MATTHEUSSENS

Ended
Nadine Maes

Bestuurder · since 10 juillet 2003

Ended
Nadine Maes

Director · since 10 juillet 2003

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates23/02/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates26/04/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates29/02/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other22/02/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - DIVERSEN - ALGEMENE VERGADERING - BOEKJAAR
    PDF
  • Mandates31/10/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates24/03/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office14/07/2021
    MAATSCHAPPELIJKE ZETEL - WIJZIGING RECHTSVORM
    PDF
  • Restructuring31/10/2018
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2026
    Annual accounts 2026112,1 k €
  2. 2025
    Annual accounts 2025607,6 k €
  3. 2024
    Annual accounts 2024808,3 k €
  4. 2022
    Annual accounts 20221,4 M €
  5. 2021
    Annual accounts 20211,3 M €
  6. 2008
    Annual accounts 2008102,3 k €
  7. 2007
    Annual accounts 2007104,2 k €
  8. 2006
    Annual accounts 200643,1 k €
  9. 23/07/2003
    IncorporationPrivate limited company